Home/Filings/4/0001753926-24-000984
4//SEC Filing

Kaufman Jonathan H 4

Accession 0001753926-24-000984

CIK 0001347242other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 4:39 PM ET

Size

5.8 KB

Accession

0001753926-24-000984

Insider Transaction Report

Form 4
Period: 2024-05-14
Kaufman Jonathan H
DirectorSee remarks below.10% Owner
Transactions
  • Purchase

    Common Stock

    2024-05-14$0.76/sh+10,000$7,590898,849 total
Footnotes (3)
  • [F1]Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
  • [F2]Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 14, 2024 at prices ranging from $0.7552 to $0.76 per share, inclusive. The amount reflected has been rounded to 3 decimal points.
  • [F3]The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

Documents

1 file

Issuer

LIPELLA PHARMACEUTICALS INC.

CIK 0001347242

Entity typeother

Related Parties

1
  • filerCIK 0001959250

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:39 PM ET
Size
5.8 KB